Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
Education Center - SponsoredAlternative therapies for improving quality of life in senior petsby • VetriScience Pro LineAdvances in veterinary medicine and animal nutrition have resulted in pets living longer than ever before. That leaves an increasing number of cats and dogs prone to common age-related problems.
Preventative for deadly puppy disease may be imminentSeptember 18, 2020An efficacy study of a monoclonal antibody targeting canine parvovirus has shown complete efficacy in its prevention, its maker says.
Canine parvovirus treatment may be in the worksAugust 19, 2019Veterinarians may soon have access to an antibody effective in the treatment of canine parvovirus (CPV).